Add like
Add dislike
Add to saved papers

Identification and Characterization of Menadione and Benzethonium Chloride as Potential Treatments of Pierce's Disease of Grapevines.

Phytopathology 2018 November 9
Xylella fastidiosa infects a wide range of plant hosts and causes Pierce's disease (PD) of grapevines. The Type 1 multidrug resistance (MDR) efflux system is essential for pathogenicity and survival of bacterial pathogens in planta. X. fastidiosa, with a single MDR system, is significantly more vulnerable to inhibition by small molecule treatments than most bacterial pathogens that typically carry redundant MDR systems. A high throughput cell viability assay using a GFP-marked strain of X. fastidiosa Temecula 1 was developed to screen two Prestwick combinatorial small molecule libraries of FDA and EMA approved drugs and phytochemicals (1600 chemicals in total) for cell growth inhibition. The screens revealed 215 chemicals that inhibited bacterial growth by greater than 50% at 50 µM concentrations. Seven chemicals proved to lyse X. fastidiosa cells at 25 µM, including four phytochemicals. Menadione (2-methyl-1,4-naphthoquinone, Vitamin K) from the phytochemical library, and benzethonium chloride (a topical disinfectant) from the chemical library both showed significant bactericidal activity against X. fastidiosa. Both menadione and benzethonium chloride foliar spray (15 mM and 5 mM, respectively) and soil drench (5 mM and 25 mM, respectively) treatments were equally effective in reducing PD symptoms by 54% - 59% and revealed that the effects of both chemical treatments became systemic. However, menadione was phytotoxic when applied as a foliar spray at effective concentrations, causing significant loss of photosynthetic capacity.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app